Similarly, ZC3H13 and TRDMT1, despite inclusion in multiple prognostic signatures (e.g., BLCA and CESC), showed moderate-to-low expression in fibroblasts and immune cells, supporting roles in stromal remodeling rather than direct tumor cell regulation [126]. Here, TRDMT1 is linked to bladder transitional cell carcinoma.